SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
F5, Inc. (FFIV) trades at a trailing P/E of 24.8, forward P/E of 18.5. Trailing earnings yield is 4.04%, forward earnings yield 5.40%. PEG 1.05. Graham Number is $130.04.
Criteria proven by this page:
- VALUE (36/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
- Forward P/E 18.5 (down from trailing 24.8) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 1.05 — between 1.0–2.0 indicates moderate valuation relative to growth.
- Trailing Earnings Yield 4.04% — roughly competitive with bond yields (~4.3%), moderate risk-reward. Forward yield improves to 5.40% as earnings recover.
- Analyst consensus target $330.67 (+12% upside) — modest upside expected.
Overall SharesGrow Score: 73/100 with 5/7 criteria passed.
SharesGrow 7-Criteria Score
✗
VALUE
36/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — FFIV
Valuation Multiples
P/E (TTM)24.8
Forward P/E18.5
PEG Ratio1.05
Forward PEG0.53
P/B Ratio4.94
P/S Ratio5.48
EV/EBITDA18.5
Per Share Data
EPS (TTM)$12.25
Forward EPS (Est.)$15.94
Book Value / Share$61.37
Revenue / Share$54.54
FCF / Share$14.94
Yields & Fair Value
Earnings Yield4.04%
Forward Earnings Yield5.40%
Dividend Yield0.00%
Graham Number$130.04
SharesGrow IV$370.58 (+25.5%)
Analyst Target$330.67 (+12%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
23.0 |
3.24 |
7.09 |
4.21 |
- |
| 2017 |
18.4 |
0.88 |
6.29 |
3.70 |
- |
| 2018 |
25.8 |
1.99 |
9.10 |
5.41 |
- |
| 2019 |
19.7 |
-5.04 |
4.79 |
3.76 |
- |
| 2020 |
24.3 |
-0.84 |
3.35 |
3.18 |
- |
| 2021 |
36.4 |
4.49 |
5.11 |
4.64 |
- |
| 2022 |
27.1 |
-12.32 |
3.53 |
3.24 |
- |
| 2023 |
24.4 |
1.04 |
3.45 |
3.43 |
- |
| 2024 |
22.8 |
0.49 |
4.13 |
4.59 |
- |
| 2025 |
27.0 |
1.13 |
5.21 |
6.06 |
- |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$5.38 |
$2B |
$365.86M |
18.3% |
| 2017 |
$6.50 |
$2.09B |
$420.76M |
20.1% |
| 2018 |
$7.32 |
$2.16B |
$453.69M |
21% |
| 2019 |
$7.08 |
$2.24B |
$427.73M |
19.1% |
| 2020 |
$5.01 |
$2.35B |
$307.44M |
13.1% |
| 2021 |
$5.34 |
$2.6B |
$331.24M |
12.7% |
| 2022 |
$5.27 |
$2.7B |
$322.16M |
12% |
| 2023 |
$6.55 |
$2.81B |
$394.95M |
14% |
| 2024 |
$9.55 |
$2.82B |
$566.78M |
20.1% |
| 2025 |
$11.80 |
$3.09B |
$692.38M |
22.4% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$15.94 |
$15.86 – $16.05 |
$3.27B |
$3.25B – $3.28B |
7 |
| 2027 |
$16.72 |
$16.32 – $17.58 |
$3.38B |
$3.31B – $3.53B |
8 |
| 2028 |
$17.53 |
$15.45 – $19.62 |
$3.43B |
$3.42B – $3.44B |
2 |
| 2029 |
$17.53 |
$17.20 – $18.12 |
$3.39B |
$3.34B – $3.47B |
1 |
